Literature DB >> 21114618

Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study.

N A Zakai1, L Lange, W T Longstreth, E S O'Meara, J L Kelley, M Fornage, D Nikerson, M Cushman, A P Reiner.   

Abstract

BACKGROUND: Thrombosis and inflammation are critical in stroke etiology, but associations of coagulation and inflammation gene variants with stroke, and particularly factor VII levels, are inconclusive.
OBJECTIVES: To test the associations between 736 single-nucleotide polymorphisms (SNPs) between tagging haplotype patterns of 130 coagulation and inflammation genes, and stroke events, in the 5888 participants aged ≥ 65 years of the observational Cardiovascular Health Study cohort. PATIENTS/
METHODS: With 16 years of follow-up, age-adjusted and sex-adjusted Cox models were used to estimate associations of SNPs and FVIIc levels with future stroke.
RESULTS: Eight hundred and fifteen strokes occurred in 5255 genotyped participants without baseline stroke (748 ischemic strokes; 586 among whites). Among whites, six SNPs were associated with stroke, with a nominal P-value of < 0.01: rs6046 and rs3093261 (F7); rs4918851 and rs3781387 (HABP2); and rs3138055 (NFKB1A) and rs4648004 (NFKB1). Two of these SNPs were associated with FVIIc levels (units of percentage activity): rs6046 (β = -18.5, P = 2.38 × 10(-83)) and rs3093261 (β = 2.99, P = 3.93 × 10(-6)). After adjustment for age, sex, race, and cardiovascular risk factors, the association of FVIIc quintiles (Q) with stroke were as follows (hazard ratio; 95% confidence interval): Q1, reference; Q2, 1.4, 1.1-1.9); Q3, 1.1, 0.8-1.5); Q4, 1.5, 1.1-2.0); and Q5, 1.6, 1.2-2.2). Associations between SNPs and stroke were independent of FVIIc levels.
CONCLUSIONS: Variations in FVII-related genes and FVIIc levels were associated with risk of incident ischemic stroke in this elderly cohort, suggesting a potential causal role for FVII in stroke etiology.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21114618      PMCID: PMC3030667          DOI: 10.1111/j.1538-7836.2010.04149.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  36 in total

Review 1.  Hemostatic risk factors for atherothrombotic disease: an epidemiologic view.

Authors:  A R Folsom
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

2.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

3.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

4.  Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

Authors:  N Rifai; R P Tracy; P M Ridker
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

5.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

6.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study.

Authors:  W T Longstreth; C Bernick; A Fitzpatrick; M Cushman; L Knepper; J Lima; C D Furberg
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

7.  Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.

Authors:  Anja S Lindman; Jan I Pedersen; Harald Arnesen; Elsa M Hjerkinn; Marit B Veierød; Hans Prydz; Ingebjørg Seljeflot
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

Review 8.  Haemostatic function and arterial disease.

Authors:  T W Meade
Journal:  Br Med Bull       Date:  1994-10       Impact factor: 4.291

9.  Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.

Authors:  Michael N Diringer; Brett E Skolnick; Stephan A Mayer; Thorsten Steiner; Stephen M Davis; Nikolai C Brun; Joseph P Broderick
Journal:  Stroke       Date:  2009-12-03       Impact factor: 7.914

10.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

Authors:  G S Tell; L P Fried; B Hermanson; T A Manolio; A B Newman; N O Borhani
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

View more
  15 in total

1.  A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium.

Authors:  Kira C Taylor; Leslie A Lange; Delilah Zabaneh; Ethan Lange; Brendan J Keating; Weihong Tang; Nicholas L Smith; Joseph A Delaney; Meena Kumari; Aroon Hingorani; Kari E North; Mika Kivimaki; Russell P Tracy; Christopher J O'Donnell; Aaron R Folsom; David Green; Steve E Humphries; Alexander P Reiner
Journal:  Hum Mol Genet       Date:  2011-06-15       Impact factor: 6.150

Review 2.  The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease.

Authors:  Nicolas Roberto Robles
Journal:  Clin Drug Investig       Date:  2016-06       Impact factor: 2.859

3.  Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables.

Authors:  Lu-Chen Weng; Weihua Guan; Lyn M Steffen; James S Pankow; Nathan Pankratz; Ming-Huei Chen; Mary Cushman; Saonli Basu; Aaron R Folsom; Weihong Tang
Journal:  Thromb Res       Date:  2018-06-01       Impact factor: 3.944

4.  Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.

Authors:  N C Olson; L M Raffield; L A Lange; E M Lange; W T Longstreth; G Chauhan; S Debette; S Seshadri; A P Reiner; R P Tracy
Journal:  J Thromb Haemost       Date:  2017-12-08       Impact factor: 5.824

5.  The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Elfie Kathrin Roedel; Elisabeth Schwarz; Sandip Madhav Kanse
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

6.  Long- and Short-term Exposure to Air Pollution and Inflammatory/Hemostatic Markers in Midlife Women.

Authors:  Rochelle Green; Rachel Broadwin; Brian Malig; Rupa Basu; Ellen B Gold; Lihong Qi; Barbara Sternfeld; Joyce T Bromberger; Gail A Greendale; Howard M Kravitz; Kristin Tomey; Karen Matthews; Carol A Derby; Elizabeth A Jackson; Robin Green; Bart Ostro
Journal:  Epidemiology       Date:  2016-03       Impact factor: 4.822

7.  Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers.

Authors:  I-Ming Wang; Bin Zhang; Xia Yang; Jun Zhu; Serguei Stepaniants; Chunsheng Zhang; Qingying Meng; Mette Peters; Yudong He; Chester Ni; Deborah Slipetz; Michael A Crackower; Hani Houshyar; Christopher M Tan; Ernest Asante-Appiah; Gary O'Neill; Mingjuan Jane Luo; Rolf Thieringer; Jeffrey Yuan; Chi-Sung Chiu; Pek Yee Lum; John Lamb; Yves Boie; Hilary A Wilkinson; Eric E Schadt; Hongyue Dai; Christopher Roberts
Journal:  Mol Syst Biol       Date:  2012-07-17       Impact factor: 11.429

8.  Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?

Authors:  Robert C Barber; Nicole R Phillips; Jeffrey L Tilson; Ryan M Huebinger; Shantanu J Shewale; Jessica L Koenig; Jeffrey S Mitchel; Sid E O'Bryant; Stephen C Waring; Ramon Diaz-Arrastia; Scott Chasse; Kirk C Wilhelmsen
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

9.  A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.

Authors:  Paul S de Vries; Maria Sabater-Lleal; Jennifer E Huffman; Jonathan Marten; Ci Song; Nathan Pankratz; Traci M Bartz; Hugoline G de Haan; Graciela E Delgado; John D Eicher; Angel Martinez-Perez; Cavin K Ward-Caviness; Jennifer A Brody; Ming-Huei Chen; Moniek P M de Maat; Mattias Frånberg; Dipender Gill; Marcus E Kleber; Fernando Rivadeneira; José Manuel Soria; Weihong Tang; Geoffrey H Tofler; André G Uitterlinden; Astrid van Hylckama Vlieg; Sudha Seshadri; Eric Boerwinkle; Neil M Davies; Anne-Katrin Giese; M Kamran Ikram; Steven J Kittner; Barbara McKnight; Bruce M Psaty; Alex P Reiner; Muralidharan Sargurupremraj; Kent D Taylor; Myriam Fornage; Anders Hamsten; Winfried März; Frits R Rosendaal; Juan Carlos Souto; Abbas Dehghan; Andrew D Johnson; Alanna C Morrison; Christopher J O'Donnell; Nicholas L Smith
Journal:  Blood       Date:  2019-01-14       Impact factor: 25.476

Review 10.  Sex differences in predictors of ischemic stroke: current perspectives.

Authors:  Alyana A Samai; Sheryl Martin-Schild
Journal:  Vasc Health Risk Manag       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.